Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca rallies as Trump said to consider fast-tracking Covid vaccine

Mon, 24th Aug 2020 11:46

(Sharecast News) - AstraZeneca shares rallied on Monday after it emerged that US President Donald Trump is considering fast-tracking an experimental Covid-19 vaccine being developed by the pharmaceuticals giant and Oxford University.
The Financial Times cited three people briefed on the plan as saying that one option being considered involves the US Food and Drug Administration awarding the vaccine 'emergency use authorisation' (EUA) in October, based on the results from a relatively small UK study if it is successful.

The AstraZeneca study falls short of the number of participants required for FDA approval. The company has enrolled 10,000 volunteers, whereas the US government's scientific agencies have said a vaccine would need to be studied in 30,000 people to pass the threshold for authorisation.

In July, AstraZeneca said that the vaccine had produced a "strong immune response" in Phase I/II trial results.

At 1155 BST, the shares were up 3.9% at 8,762.54p.

CMC Markets analyst David Madden said: "Mr Trump will be contesting the US presidential election in November so he is keen to get a grip on the health crisis. The drug in question still has a long way to go in terms of development, but the bulls have jumped on the story."

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.